« Return to News | Ethics/Regulatory

Schulman Associates IRB acquires Independent IRB

Monday, December 5, 2011 11:18 AM

Schulman Associates Institutional Review Board has acquired Independent
Investigational Review Board. The transaction allows both organizations, which protect the rights of human research subjects, to provide a more comprehensive suite of review services for pharmaceutical, medical device, contract research organization and clinical research site customers.

"The strengths of the two organizations are remarkably complimentary," said Michael Woods, president and CEO of Schulman. "We are very excited by the added resources and capabilities Independent brings to the combined company."

With offices in Cincinnati, Ohio, and Plantation, Fla., the combined organization will provide research review services for a broad range of therapeutic areas and types of human subject research. Separately, each organization is accredited by Association for the Accreditation of Human
Research Protection Programs (AAHRPP), and each has a clean recent audit
history with FDA.

"Joining with Schulman allows Independent to provide the advantages of enhanced WebPortal and IT features to our established customer base," said Kim Lerner, outgoing CEO of Independent.

Anita McSharry, former president of Independent, added, "This is a perfect example of one plus one equaling far more than two. The benefits extend to every research site, sponsor and CRO that uses our services. The employees
of both companies also benefit from the additional resources that allow them to accomplish their mission to protect the rights of human research subjects more efficiently than ever."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.